Unit notes

A receptor is a molecule that binds a suitable signal. A phosphate group can change a protein’s activity when added or removed; phosphorylation does not always turn a protein on. Negative feedback counteracts a deviation, while positive feedback amplifies a change until another event stops the process.

A cell responds to a signal only if it has suitable recognition machinery. Local signals can diffuse to nearby cells, while endocrine signals can travel through the body. Contact-dependent interactions require cells or surface molecules to meet. Signal range does not determine the size of the response.

Hydrophilic ligands often bind cell-surface receptors because they cannot freely cross the lipid bilayer. Some small hydrophobic signals bind intracellular receptors. Binding changes receptor activity and begins transduction. The same extracellular signal can cause different responses in cells with different downstream proteins or transcriptional states.

A signaling cascade may activate protein kinases, second messengers, or other intermediates. Kinases transfer phosphate groups, often from ATP, to target proteins; phosphatases remove phosphate groups. Phosphorylation can activate or inhibit a protein depending on that protein’s structure.

Amplification occurs when one activated component influences many downstream molecules. A small amount of signal can therefore produce a large response. Pathways must also be turned off: ligand removal, GTP hydrolysis, messenger breakdown, and phosphatase activity can restore the resting state. Persistent signaling is not automatically beneficial.

If a receptor inhibitor prevents a response but a downstream activator restores it, the downstream component may bypass the inhibited step. This logic helps place components in a pathway. It does not prove direct physical contact between every consecutive component.

A convincing experiment compares a treatment with an appropriate control and measures a defined response, such as reporter expression or phosphorylated protein abundance. Control solvent, dose, exposure time, cell number, and background activity. A failure to respond could result from toxicity rather than specific pathway inhibition, so viability may need a separate control.

Negative feedback reduces deviation from a regulated condition. A response opposing increased blood glucose, for example, can help restore a range rather than a single perfectly fixed value. Positive feedback amplifies a change until an outside event or limiting condition ends the loop. Positive does not mean healthy, and negative does not mean harmful.

Homeostatic models include a variable, a detection mechanism, a response, and an effect on the original variable. When explaining a loop, state each link. Merely writing “homeostasis occurs” does not explain how a change is corrected.

During interphase, a cell grows, replicates DNA in S phase, and prepares for division. Mitosis separates replicated chromosomes into daughter nuclei, while cytokinesis divides the cytoplasm. Count chromosomes by centromeres under the usual convention: DNA replication doubles DNA content without immediately doubling chromosome number.

Cyclins and cyclin-dependent kinases help regulate progression. Checkpoints can delay division when DNA is damaged, replication is incomplete, or chromosomes are not properly attached to the spindle. Loss of growth-control mechanisms can contribute to cancer. Apoptosis is regulated cell death that can remove damaged or unnecessary cells; it is not the same as accidental tissue injury.

A signaling molecule is a ligand. A hydrophilic ligand generally binds a receptor at the cell surface because it does not readily cross the lipid bilayer. Some small hydrophobic ligands cross the membrane and bind intracellular receptors. Receptor binding changes receptor activity, which initiates a sequence of intracellular events. Different cells can respond differently to the same ligand if they have different receptors or downstream machinery.

A kinase transfers phosphate groups to target molecules; a phosphatase removes them. Second messengers such as cyclic AMP or calcium can distribute and amplify a signal. Amplification means one activated molecule can influence many downstream molecules, not that the original ligand becomes more concentrated. Signal termination is as important as activation: ligand removal, receptor inactivation, messenger breakdown, and dephosphorylation help prevent persistent inappropriate responses.

Suppose a pathway is receptor → kinase A → kinase B → transcription factor. If an active form of B restores the response when A is inhibited, B can plausibly act downstream of A. If adding more ligand cannot restore the response when the receptor is absent, the receptor is required for normal signal reception. These are conditional conclusions about the tested model, not proof that the cell has no alternative pathways.

Always distinguish a loss-of-function treatment from a constitutively active component. Blocking a protein tells you what fails without it. Activating a downstream protein can bypass an upstream requirement. Include untreated and vehicle controls and confirm that cells remain viable. A treatment that kills cells can reduce every measured response without specifically implicating the proposed pathway.

Cells can communicate through direct contact, local signals or signals transported over longer distances. A locally released signal may act on nearby cells, while a hormone can reach distant tissues through circulation. Delivery describes how a signal reaches a potential target, not whether that target is able to respond.

A cell typically needs a suitable receptor and functioning downstream machinery to respond. Two cells exposed to the same signal may differ because they express different receptors or intracellular components. Presence of the signal in a tissue is therefore not proof that every cell in that tissue responds.

A failed response could arise because a signal was not delivered, a receptor is missing, or later steps failed. An experiment that supplies the signal directly can help test delivery, but it does not by itself isolate receptor function. Design comparisons that distinguish stages instead of treating communication as one indivisible event.

Large or strongly polar signals often cannot freely cross the nonpolar membrane interior and can bind cell-surface receptors. Some small hydrophobic signals can enter and bind intracellular receptors. These are useful chemical patterns rather than permission to infer a complete pathway from one property alone.

A ligand binds an appropriate receptor through compatible molecular interactions. Binding can change the receptor’s conformation or activity, initiating downstream events. The signal does not have to become a nutrient or be physically carried all the way to the final response site. Recognition can trigger information transfer across the membrane.

Even normal ligand binding may fail to produce a response if the receptor cannot activate downstream machinery. Conversely, a receptor might become active without its normal ligand after a structural change. Measure binding and downstream activity separately to locate which function has changed.

Reception is detection of the signal by an appropriate receptor. Transduction converts that event into intracellular changes through one or more relay steps. The response is the resulting cellular change, such as altered enzyme activity, secretion or gene expression. These labels describe functions within a pathway; real pathways can branch and interact.

Some responses modify proteins already present and can occur relatively quickly. Others alter transcription and subsequent protein production. A rapid response does not necessarily require a change in DNA sequence or synthesis of a new receptor. Interpret timing using the actual mechanism under study.

Blocking a relay may prevent downstream responses while leaving ligand binding intact. Artificially activating a later step may restore part of the response without repairing the blocked upstream step. Such bypass experiments help infer order, provided the manipulation is sufficiently specific and suitable controls are used.

A protein kinase transfers a phosphate group, commonly from ATP, to a target protein. The modification can alter conformation, interactions or activity. It is inaccurate to assume phosphorylation always activates a protein: the effect depends on the target and modified site. A pathway diagram should specify which state is active.

Protein phosphatases remove phosphate groups from suitable targets. Reversibility allows signals to turn on, change strength and turn off. A phosphatase is not simply “the inhibitor” in every pathway; removing phosphate may activate some proteins and inhibit others. Track the stated relationship for each target.

A cell can change activity without changing total protein abundance. Measurements of total protein and phosphorylated protein answer different questions. A rise in phosphorylation supports a state change, but predicting the functional direction requires knowing what phosphorylation does to that particular protein.

Second messengers are intracellular signaling molecules or ions, such as cAMP or Ca²⁺ in suitable pathways. They can influence downstream proteins and distribute a signal within the cell. Their concentration and location are regulated; the cell does not simply accumulate every messenger indefinitely.

One activated component can influence multiple downstream molecules, and successive stages can expand the response. This is amplification of the effect of a recognition event, not creation of energy. The reactions use available molecules and appropriate energy sources. Actual amplification depends on rates, available targets and regulation.

Messenger degradation, ion transport and removal of activating modifications can return the system toward baseline. A messenger may stay elevated if removal is impaired even after the initiating signal falls. A time course can reveal persistence that a single endpoint would miss.

Different receptor types can recognize related signals and connect to different internal routes. Even cells with similar receptors can differ in relay proteins, transcription factors or effector enzymes. Specificity is distributed through the pathway rather than determined solely by where the ligand was produced.

An activated pathway may branch, affecting several targets. One branch can change an enzyme quickly while another influences gene expression over a longer interval. A treatment blocking one branch need not eliminate all responses to the original signal. Distinguish a measured endpoint from the complete cellular response.

Physical organization can bring suitable signaling components together and limit inappropriate interactions. The same chemical modification can therefore have different effects depending on which proteins meet and where. Predictions should refer to the actual components and context given rather than assuming identical wiring in all cells.

Interphase includes G₁, S and G₂ in a typical cycling cell. The cell grows and carries out functions; DNA is replicated during S phase, and preparation continues before division. Interphase is not a period when the cell is inert. Some cells leave the active cycle into a nondividing state rather than repeatedly cycling at one fixed rate.

Replication produces sister chromatids associated as a duplicated chromosome. Mitosis then distributes the duplicated genetic material into nuclei. Cytokinesis partitions the cytoplasm. Copying DNA, dividing a nucleus and dividing a cell are related but distinct events that can be separately disrupted.

Different cell types and conditions produce different phase durations. A diagram drawn with equal-sized phase sectors does not establish equal time in each phase. Experimental measurements are needed to infer duration, and a snapshot sample requires additional assumptions before percentages are converted into times.

As mitosis begins, chromosomes condense and the spindle forms. In typical open mitosis, the nuclear envelope breaks down and spindle microtubules interact with chromosomes through kinetochores. At metaphase, chromosomes are arranged for segregation. A drawing of alignment is a snapshot of a dynamic attachment system, not a static decorative line.

During anaphase, sister chromatids separate and move toward opposite poles. Once separated, each chromatid is counted as a chromosome. This distribution normally gives each daughter nucleus one copy of each chromosome present before replication, assuming normal segregation and no preceding mutation or chromosome abnormality.

In telophase, chromosomes arrive at the poles, nuclear organization is re-established and chromosomes decondense. Cytokinesis commonly overlaps late mitosis but is conceptually distinct. Failure of cytokinesis can leave multiple nuclei in one cell rather than automatically preventing nuclear division.

Before sister chromatids separate, a duplicated chromosome is still counted as one chromosome with two sister chromatids. Thus a diploid cell with 2n=6 typically has six chromosomes before and after S phase, but twelve chromatids after replication. DNA amount has doubled even though the chromosome count under this convention has not.

At anaphase, separated sisters become individual chromosomes. Before the cell divides, the whole cell temporarily contains twelve chromosomes in this example, with six moving toward each pole. After normal division, each daughter has six chromosomes. Specify whether the question asks about the whole cell, one pole or one daughter nucleus.

Ploidy describes sets of homologous chromosomes, not the total amount of DNA. S phase does not normally convert a diploid cell into a tetraploid one simply by making sisters. Homologs and sisters describe different relationships: homologs carry corresponding gene loci; sisters arise through replication of a chromosome.

Cyclin-dependent kinases participate in regulating cell-cycle transitions. Their activity depends on suitable cyclin partners and additional regulatory conditions. Cyclin abundance can rise and fall during the cycle. A constant kinase amount therefore does not imply constant kinase activity or constant permission to divide.

Active complexes modify targets that help coordinate transitions. Regulation can involve synthesis, degradation and activating or inhibitory modifications. The exact response depends on the proteins in the pathway. Do not infer a complete transition solely from one measured protein’s total concentration.

Preventing degradation of a regulator may prolong its influence, but the outcome depends on its role and other controls. Measure activity and downstream events, not just abundance. When analyzing a proposed mechanism, identify what changes, what remains, and which transition should be affected.

Cell-cycle controls can respond to DNA damage, completion of replication and appropriate chromosome attachment. Delaying a transition can provide time for repair or prevent faulty segregation. A checkpoint is a regulatory process, not a physical place where the cell waits.

Anaphase should not proceed normally before chromosomes are appropriately attached for segregation. Defective attachment can activate a delay. If the control fails, chromosome distribution may be abnormal. A treatment causing an arrest and a mutation that abolishes arrest can have very different consequences even if both alter cell division.

An accumulation of cells before a transition may reflect a working checkpoint responding to another defect. It does not prove the treatment directly binds the checkpoint regulator. Distinguish the initiating damage, the sensor/control response and the downstream arrest.

Cells can activate repair processes, delay the cycle, enter a persistent nondividing state or undergo programmed cell death, depending on damage and regulatory context. A short observation window may show arrest without revealing the final fate. Follow cells over time to distinguish temporary delay from a more persistent outcome.

Apoptosis is a regulated cell-death process involving coordinated cellular changes. It can help remove damaged or unneeded cells. It is not synonymous with every kind of cell damage or accidental rupture. A decrease in cell number alone does not establish apoptosis without additional evidence.

Measure viability, cycling and relevant molecular or structural indicators rather than treating one endpoint as a complete diagnosis of cell fate. A treatment that lowers population growth might slow division, increase death or do both. Counts over time and appropriate markers help distinguish the contributions.